Home NDC 62032-413 Tretinoin
Product NDC 62032-413
11-digit product format 620320413
Labeler code 62032
Product ID 62032-413_cf3898ce-f8a0-4e8f-a237-a8d87e3c20a3
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Tretinoin
Dosage form GEL
Route TOPICAL
Labeler Obagi Cosmeceuticals LLC
Application NDA022070
Marketing category NDA AUTHORIZED GENERIC
Marketing start 2014-06-19
Substance TRETINOIN
Active strength .05 g/100g
Pharmacologic classes Retinoid [EPC], Retinoids [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N022070-001 ATRALIN TRETINOIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N022070-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N022070-001 ATRALIN 0.05% GEL / TOPICAL AB RLD, RS 2007-07-26 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Tretinoin
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength TRETINOIN .05 g/100g
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 5688UTC01R Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 245723 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 62032-413-20 Tretinoin 20 g in 1 TUBE GEL 20 10
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded TRETINOIN ACTIVE INGREDIENT 5688UTC01R TRETINOIN GEL [OMP, INC.] 2 TRETINOIN ACTIVE MOIETY 5688UTC01R TRETINOIN GEL [OMP, INC.] 2 BENZYL ALCOHOL INACTIVE INGREDIENT LKG8494WBH TRETINOIN GEL [OMP, INC.] 2 BUTYLATED HYDROXYTOLUENE INACTIVE INGREDIENT 1P9D0Z171K TRETINOIN GEL [OMP, INC.] 2 BUTYLPARABEN INACTIVE INGREDIENT 3QPI1U3FV8 TRETINOIN GEL [OMP, INC.] 2 CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) INACTIVE INGREDIENT 4Q93RCW27E TRETINOIN GEL [OMP, INC.] 2 ETHYLPARABEN INACTIVE INGREDIENT 14255EXE39 TRETINOIN GEL [OMP, INC.] 2 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX TRETINOIN GEL [OMP, INC.] 2 HYALURONATE SODIUM INACTIVE INGREDIENT YSE9PPT4TH TRETINOIN GEL [OMP, INC.] 2 ISOBUTYLPARABEN INACTIVE INGREDIENT 0QQJ25X58G TRETINOIN GEL [OMP, INC.] 2 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T TRETINOIN GEL [OMP, INC.] 2 OCTOXYNOL-9 INACTIVE INGREDIENT 7JPC6Y25QS TRETINOIN GEL [OMP, INC.] 2 PHENOXYETHANOL INACTIVE INGREDIENT HIE492ZZ3T TRETINOIN GEL [OMP, INC.] 2 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH TRETINOIN GEL [OMP, INC.] 2 TROLAMINE INACTIVE INGREDIENT 9O3K93S3TK TRETINOIN GEL [OMP, INC.] 2 WATER INACTIVE INGREDIENT 059QF0KO0R TRETINOIN GEL [OMP, INC.] 2
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 62032-413 TRETINOIN GEL [OBAGI COSMECEUTICALS LLC] 9 Current NDC, Legacy NDC, 1 package rows 20210729_c5ee36ac-2ffd-4cca-ad47-b1dae7ebdb3b.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 62032-413-20 62032041320 20 g in 1 TUBE (62032-413-20) 20 g 2014-06-19 0000-00-00 No No Current